Lung Neoplasms: all 7,334 studies
Page 42 of 74. Open to participants first (1,555), then studies with results posted, then the rest; newest registration first within each.
- Toripalimab in Combination With Platinum Plus Etoposidein Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT04012606Phase 3
- Evaluation of the Quality of Life of Patients With Metastatic Non-small Cell Lung Cancer With Supplementary Therapy With IGEN-0206CompletedNCT04009122Not applicable
- Sonidegib and Pembrolizumab in Treating Patients With Advanced Solid TumorsActive, not recruitingNCT04007744Phase 1
- Maine Lung Cancer Coalition: Using CHWs for the Annual Lung Cancer Screening ReminderCompletedNCT04007458Not applicable
- FDG PET/CT Radiomics Analyses of Lung Cancer Patients Treated With ImmunotherapyCompletedNCT04007068
- ENB Guided MWA for Early-stage Peripheral Lung CancerStatus unknownNCT04005157Not applicable
- Brigatinib and Binimetinib in Treating Patients With Stage IIIB-IV ALK or ROS1-Rearranged Non-small Cell Lung CancerTerminatedNCT04005144Phase 1
- Impact of Risk for OSA in Lung CancerCompletedNCT04003961
- Efficacy of metfOrmin in PrevenTIng Glucocorticoid-induced Diabetes in Patients With Brain MetastasesStatus unknownNCT04001725Phase 2
- Imaging-based Deep Learning for Lung Cancer Diagnosis and StagingStatus unknownNCT04000620
- Determining Whether Durvalumab in Combination With Radiation Therapy Can Prevent the Progression of Non-Small Cell Lung CancerActive, not recruitingNCT03999710Phase 2
- Overall Survival of Large Cell Neuroendocrine Lung Cancer Patients - a Retrospective StudyCompletedNCT03998332
- Anlotinib Single Drug as the Maintenance Treatment for Advanced NSCLCStatus unknownNCT03998085Not applicable
- Comparison of Two Techniques of Uniportal VATS Lobectomies for Clinical Stage I Non-Small Cell Lung CancerStatus unknownNCT03997799Not applicable
- Assessing Safety and Efficacy of Sintilimab and Metformin Combination Therapy in SCLCStatus unknownNCT03994744Phase 2
- Non Small Cell Lung Cancer Trial of Durvalumab and Tremelimumab in Advanced Epidermal Growth Factor Receptor (EGFR) Mutant Disease.Status unknownNCT03994393Phase 2
- Study of TPX-0022 in Patients With Advanced NSCLC, Gastric Cancer or Solid Tumors Harboring Genetic Alterations in METActive, not recruitingNCT03993873Phase 1
- Methods of Computed Tomography Screening and Management of Lung CancerStatus unknownNCT03992833Not applicable
- Study of Atezolizumab Combination Carboplatin + Paclitaxel + Bevacizumab in EGRF Mutation or ALK Translocation NSCLCStatus unknownNCT03991403Phase 3
- Computed Tomography Screening for Early Lung Cancer, COPD and Cardiovascular Disease in Shanghai, ChinaStatus unknownNCT03988322Not applicable
- Volatile Organic Compounds in Exhaled Air and Sweat of Patients Treated by Immunotherapy for Lung Cancer: Research on Biomarkers for Early Therapeutic ResponseTerminatedNCT03988192Not applicable
- Study of Autologous CIK Cell Immunotherapy Combination With PD-1 Inhibitor and Chemotherapy in the Advanced NSCLCStatus unknownNCT03987867Phase 1
- Paclitaxel Therapeutic Drug Monitoring in Cancer PatientsSuspendedNCT03987555
- Clinical Trial of Kanglaite Injection (KLTi) in Advanced Non-Small Cell Lung Cancer (NSCLC)Status unknownNCT03986528Phase 4
- CIrculating Tumour DNA in Lung Cancer (CITaDeL): Optimizing Sensitivity and Clinical UtilityCompletedNCT03986463
- Cardiac Changes After Stereotactic Radiotherapy for Early Stage NSCLC Cancer or Lung MetastasisTerminatedNCT03984019Not applicable
- Study of TQB2450 Combined With Anlotinib in the Treatment of Mutation Positive Lung CancerStatus unknownNCT03983928Phase 1/2
- Study of Sintlimab Maintenance Therapy in Patients With Extensive Small Cell Lung CancerStatus unknownNCT03983759Phase 2
- EUS-B-FNA in the Diagnosis of Malignant Parenchymal Lung LesionsCompletedNCT03983005
- PDR001 + Panobinostat for Melanoma and NSCLCWithdrawnNCT03982134Phase 1
- Epidemiological Study to Assess the Prevalence of Lung CancerStatus unknownNCT03976804Not applicable
- Atezolizumab in Advanced Non-small Cell Lung Cancer With Rare Histologies (CHANCE Trial)CompletedNCT03976518Phase 2
- China Lung Cancer Screening (CLUS) Study Version 2.0Status unknownNCT03975504Not applicable
- Microdevice for Evaluating Drug Response in Site in Lung LesionsCompletedNCT03972228Early Phase 1
- Safety and Efficacy Study of TQ-B3101 in Patients With ROS1-positive Non-Small Cell Lung Cancer (NSCLC)Status unknownNCT03972189Phase 2
- PD-1 Inhibitors Consolidation in Extensive-stage Small Cell Lung CancerStatus unknownNCT03971214Phase 1
- Safety, Immunogenicity and Preliminary Clinical Activity Study of PDC*lung01 Cancer Vaccine in NSCLCActive, not recruitingNCT03970746Phase 1/2
- Neck Ultrasound by Respiratory Physicians in Patients With Lung CancerCompletedNCT03970564
- Beyond the Lung Cancer Diagnosis: Leveraging the Oncology Clinic Setting for Actively Smoking Family MembersTerminatedNCT03966807
- Lung Cancer Screening ProtocolCompletedNCT03958253Not applicable
- Natural Killer(NK) Cell Combined With Programmed Death-1(PD-1) Antibody as Second Line Therapy for Advanced Driver Mutation Negative Non-small Cell Lung CancerCompletedNCT03958097Phase 2
- Clinical Significance of Computer Aided Image Analysis in Treatment Response Evaluation of Lung CancerStatus unknownNCT03954847
- K-RAS and EGFR in Lung CancerCompletedNCT03951233
- Study of Chemotherapy Combination With Autologous Cell Immunotherapy in the Advanced Lung CancerStatus unknownNCT03944980Phase 3
- Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD)Active, not recruitingNCT03944772Phase 2
- Genetics and Shared Decision Making in Improving Care for Patients With Stage IVA-C Non-small Cell Lung CancerCompletedNCT03944265Not applicable
- Anlotinib Therapy in Patients With Advanced Lung Cancer.Status unknownNCT03940404
- Evaluating Mutations in MET and TP53 Among Patients Diagnosed With Squamous Cell CarcinomaStatus unknownNCT03938012
- Effect of Two Different Preoperative Training Densities in Patients With Non-small-cell Lung Cancer Before Lung Resection SurgeryCompletedNCT03936764Not applicable
- Efficacy and Safety of Omega 3 Fatty Acid Supplements on Heavy SmokersStatus unknownNCT03936621Phase 2
- Follow-up of Pulmonary Radiotoxicity for Bronchopulmonary Cancer.CompletedNCT03931356
- Proactive Outreach and Shared Decision Making in Improving Lung Cancer Screening Rates in Primary Care PatientsCompletedNCT03929926Not applicable
- Assessment of Ergonomics in 3D vs 2D Thoracoscopic LobectomyCompletedNCT03925103Not applicable
- Active Surveillance in Early Lung CancerStatus unknownNCT03923777Not applicable
- Radiotherapy and Durvalumab/Durvalumab Combo (Tremelimumab/Olaparid) for Small Cell Lung CancerActive, not recruitingNCT03923270Phase 1
- A Study to Investigate the Safety and Efficacy of Atezolizumab in Previously-Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung CancerCompletedNCT03922997Phase 3
- Lung Nodule Prospective DatabaseCompletedNCT03922828
- Study of the Decrease of Length of Stereotactic Body Radiation Therapy in Lung CancerStatus unknownNCT03921957Not applicable
- Connect Oncology Needs Evaluation ToolCompletedNCT03919864Not applicable
- A Series of Study in Testing Efficacy of Pulmonary Rehabilitation Interventions in Lung Cancer SurvivorsCompletedNCT03918538Not applicable
- TKI Followed by Thoracic Radiotherapy for Stage IV EGFR Mutant NSCLCStatus unknownNCT03916913Not applicable
- CT-guided Radioactive I-125 Seeds Implantation for Early Stage Lung CancerCompletedNCT03916367
- Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy as First Line Treatment in Patients With Advanced Non-Squamous NSCLCStatus unknownNCT03912389Phase 3
- Impact of eHealth Monitoring on Overall Survival in Patients With Metastatic NSCLC / Extensive-stage SCLC / Advanced TNBC Under First-line Treatment With Atezolizumab Plus ChemotherapyCompletedNCT03911219
- CABozantinib in Non-Small Cell Lung Cancer (NSCLC) Patients With MET DeregulationStatus unknownNCT03911193Phase 2
- Study of TQB2450 Combined With Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（NSCLC）Status unknownNCT03910127Phase 1
- Utility of LDCT in Lung Cancer Screening in a TB Endemic RegionCompletedNCT03909620Not applicable
- A Study of Famitinib in Combination With HS-10296 in Patients With EGFR-mutant NSCLCStatus unknownNCT03904823Phase 2
- CM082 and JS001 in Patients With Advanced Small-cell Lung Cancer (SCLC)Status unknownNCT03904719Phase 2
- A Study of Anti-PD1 Antibody-activated TILs in Non-small Cell Lung CancerStatus unknownNCT03903887Phase 1/2
- Effects of Transcutaneous Electrical Nerve Stimulation in Post-operative Lung CancerCompletedNCT03903276Not applicable
- Geriatric and Quality of Life Assessments in Older Patients With Non-metastatic or Metastatic Head and Neck or Lung Cancer Undergoing Surgery or Chemoradiation and Their CaregiversCompletedNCT03902535
- Pembrolizumab With Chemotherapy in Metastatic or Unresectable High Grade Gastroenteropancreatic or Lung Neuroendocrine CarcinomaWithdrawnNCT03901378Phase 2
- Hypofractionated Radiotherapy Followed by Hypo-boost for Local Advanced NSCLCCompletedNCT03900117Phase 2
- A Study of LY3295668 Erbumine in Participants With Extensive-stage Small-Cell Lung CancerCompletedNCT03898791Phase 1
- The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)Status unknownNCT03896958
- Coagulation System In STereotactic Radiotherapy Of NSCLCStatus unknownNCT03893461
- Niraparib in Combination With Osimertinib in EGFR-Mutated Advanced Lung CancerTerminatedNCT03891615Phase 1
- Clinical Study of First-line Treatment of Small Cell Lung Cancer (SCLC) With Anlotinib HydrochlorideStatus unknownNCT03890055Phase 4
- Monitoring and Telecoaching of Physical Activity in Patients With Stage III and IV Non-small Cell Lung CancerStatus unknownNCT03883243Not applicable
- The Efficacy of Shear-wave Elastography-guided Aspiration and Biopsy for Diagnosis in Lung TumorCompletedNCT03881410Not applicable
- The Lung PCA: A Multi-Dimensional Atlas of Pulmonary PremalignancyActive, not recruitingNCT03881098Not applicable
- Multidimensional Evaluation Of Daily Living Activities And Quality Of Life In Lung Cancer PatientsCompletedNCT03881046
- Sintilimab Combined With Metformin in First-Line Chemotherapy Refractory Advanced NSCLC PatientsStatus unknownNCT03874000Phase 2
- Radiomics Multifactorial Biomarker for Pulmonary NodulesCompletedNCT03872362
- Neoantigen-primed DC Vaccines Therapy for Refractory Lung CancerStatus unknownNCT03871205Phase 1
- LIFE - Lung Cancer, Immunotherapy, Frailty, EffectActive, not recruitingNCT03870464
- Electrocautery Ablation for the Prevention of Lung CancerTerminatedNCT03870152Phase 2/3
- Patient Portal and Navigation Program in Providing Information for Asian American Cancer PatientsCompletedNCT03867916Not applicable
- A Study of Anti-PD-1 AK105 in Patients With Metastatic Squamous Non-small Cell Lung CancerCompletedNCT03866993Phase 3
- A Study of Anti-PD-1 AK105 in Patients With Metastatic Nonsquamous Non-small Cell Lung CancerTerminatedNCT03866980Phase 3
- MEchanisms of Resistance in EGFR Mutated Nonpretreated Advanced Lung Cancer Receiving OSimErtibActive, not recruitingNCT03865511Phase 2
- Use of Thoracoscopic Intraoperative Lung Ultrasound to Identify Pulmonary Metastases in Patients Submitted to Pulmonary Metastasectomy With Radical Intent.Status unknownNCT03864874
- A Study of Sintilimab or Placebo in Combination With Chemotherapy as Second-line Treatment for Patients With Stage IV Nonsquamous Non-small Cell Lung Cancer With Wild-type EGFR After Failure With Platinum-Containing Chemotherapy.Status unknownNCT03863483Phase 2
- Lung Cancer Screening: A Multilevel InterventionCompletedNCT03862001Not applicable
- The Canada Lymph Node Score: A Feasibility Randomized Controlled TrialCompletedNCT03859349Not applicable
- Pharmacokinetic Boosting of OsimertinibCompletedNCT03858491Early Phase 1
- Abivertinib Maleate Versus Geifitinib in Patients With Advanced Non-small Cell Lung Cancer With Sensitive EGFR MutationStatus unknownNCT03856697Phase 3
- A Study to Evaluate the Efficacy and Safety of Toripalimab or Placebo Combined With Chemotherapy in Treatment-naive Advanced NSCLCCompletedNCT03856411Phase 3
- Lung Cancer Screening by Low Dose CT Scan in a French Department (DEP KP80)Status unknownNCT03853967Not applicable